The blockchain tool will be used in oncology clinical research and development. Patients will be able to access their data through the decentralized ledger. New York-based Embleema’s blockchain will also give clinical researchers the opportunity to monitor the safety and effectiveness of new investigational drugs.
Through the blockchain platform, patients can receive digital tokens for participating in clinical studies. The patient-focused blockchain allows users to sign smart contracts, giving anonymity to patient data. Patients can access the blockchain and alter their contracts at any time.
Patients can also share real-time healthcare data with various life science companies to improve the timeline for new drug development.
To read the full report, click here.
More articles on health IT:
Alabama health system transitions to Cerner EHR: 3 things to know
JPM cryptocoin ‘great for blockchain,’ but lacks interoperability, Ripple CEO says
Philips to acquire Carestream Health IT business: 3 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
